Acetaminophen Prices

Acetaminophen Prices December 2023

The price of acetaminophen in the United States for Q4 2023 reached 4965 USD/MT in December. Similarly, the price trend for acetaminophen in China in Q4 2023, reached 4751 USD/MT 2023. Whereas, in Germany, acetaminophen prices reached 5034 USD/MT in December.

Acetaminophen Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Acetaminophen Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of acetaminophen pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot prices at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of acetaminophen price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing acetaminophen price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Acetaminophen Market Analysis

The global acetaminophen market size reached US$ 681.69 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 980.38 Million, at a projected CAGR of 4.12% during 2023-2032.

• The rising prevalence of chronic diseases such as cancer significantly drives the acetaminophen market. According to the National Cancer Institute, 19.3 million people were diagnosed with cancer globally in 2020, with 20% to 50% experiencing pain that necessitates effective analgesics like acetaminophen. This trend is anticipated to intensify as the global population ages, leading to an expected 21.7 million additional cancer cases by 2030​​. The widespread use of acetaminophen as a first-line treatment for pain due to its effectiveness and safety profile further bolsters its market demand.
• Due to the opioid crisis, societies in developed countries are gradually changing the approaches to the treatment of chronic pain to minimize the use of opioids. Non-opioid analgesics like Paracetamol are being recommended by Governments and healthcare providers because of their non-addictive nature and recognized safety profile. This change has presented a clear opportunity for acetaminophen given the efforts of pharmaceutical corporations to extend their portfolios to accommodate the growing need for relatively safer products. As per the 2021 report of the U. S. Department of Health and Human Services revealed that opioid prescriptions in America fell by 44 percent. Conversely, the use of non-opioid analgesics such as acetaminophen was on the rise during the same period. Furthermore, the CDC indicated that there are non-opioid interventions for chronic pain management that patients have benefitted from. Healthcare facilities all over the world today are embracing non-opioid interventions hence anticipating a better market for acetaminophen.
• The growing concern for chronic pain management and the aging population are two more factors that will further boost the acetaminophen market. Chronic pain is one of the major fields wherein non-opioid treatment options are becoming more and more popular. Based on the data presented from the National Institutes of Health (NIH) 2021 report, about 20 % of adults in the United States suffer from chronic pain and are in search of non-opioid pain management. The CDC has endorsed acetaminophen for the management of several chronic pains hence its increased usage.
• Apart from this, due to the increased life expectancy of individuals, the demand for safer analgesics has substantially shifted. According to the U. S. Census Bureau data, in 2021, the population of people aged 65 and older was over 54 million and this figure is projected to increase significantly in the future years. This demographic is especially vulnerable to diseases associated with pain management such as arthritis and musculoskeletal disorders. Due to the better safety profile in the long-term use of acetaminophen, it is often used to manage pain, especially in the aging population thereby fueling the market growth as more players in the pharmaceutical industry introduce products targeting this population.

Acetaminophen News

The report covers the latest developments, updates, and trends impacting the global acetaminophen market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in acetaminophen production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the acetaminophen price trend.

Latest developments in the acetaminophen industry:

• In April 2023, WhiteGrey for a global consumer healthcare provider Haleon launched their PanaNatra, the first pain relief medication produced organically in the market. PanaNatra was introduced with a marketing slogan ‘Who Said Natural Hasn’t Got What it Takes,’ the first product in the new naturals segment from the marketers of Panadol.
• In October 2023, the FDA approved Combogesic IV, which is manufactured as Maxigesic IV outside the United States and is an intravenous formulation of acetaminophen and ibuprofen for the control of postoperative pain. It may provide an option for postoperative pain control that is as efficient as the existing methods used in clinical practice.

Product Description

Acetaminophen is a common OTC drug used predominantly for its pain-relieving and fever-fighting abilities or as an analgesic and antipyretic respectively. Originally found in the late 1800s, though not marketed until the middle of the 1900s, acetaminophen is today among the most ingested drugs worldwide.

It reduces pain perception by preventing the production of prostaglandins which are used by the brain to transmit pain and regulate temperature. In contrast to NSAIDs such as ibuprofen, acetaminophen lacks a powerful anti-inflammatory effect but has a mere impact on the gastrointestinal tract, which may be crucial for those with certain types of sensitivity. But more attention should be paid to acetaminophen consumption, which, if taken in excessive doses, can cause severe liver failure. This means it is present in many over-the-counter products such as those used in treating colds, flu, and other minor ailments hence the need to closely supervise the average daily consumption to avoid an overdose in the form of toxicity.

Regional Coverage

The report provides a detailed analysis of the acetaminophen market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the acetaminophen price trend. 

Global Acetaminophen Price

The report offers a holistic view of the global acetaminophen pricing trends, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level.

Europe Acetaminophen Price

In the fourth quarter of 2023, the EU Commission fines the major pharmaceutical companies on charges of collusion to fix prices. At the same time, with the stabilization of the European economy and high interest rates within the banking sector, the levels of lending to the pharmaceutical industry reduced considerably. Due to profit margin declines companies opted for increasing product prices such as acetaminophen. In any case, governments forced manufacturers to reduce the market prices, and it affected the changes in the acetaminophen price graph. This change exemplifies the tension in this industry between market logics and regulation, in which the quest for profit may run counter to the concerns of affordability and fair competition. Such occurrences highlight the need for constant monitoring to avoid anti-competitive conduct and protect the interest of consumers in markets as important as healthcare.

This analysis can be extended to include detailed acetaminophen price information for a comprehensive list of countries.

North America Acetaminophen Price

Due to the high prices of Acetaminophen, the North America government put measures that prohibited producers from increasing the prices higher than inflation rates. Nonetheless, major pharmaceutical companies opposed these actions, leading to a legal dispute that distorted the acetaminophen price pattern. Further, drought in the Panama Canal impacted the shipment of raw materials hence increasing the production costs and affecting the stability of the pharmaceutical industry in the fourth quarter of the year 2023. All the above factors highlight that multiple layer of regulation policies and market forces as well as other forces, such as natural catastrophes, influence the affordability and accessibility of vital medicine essentiality for consumers.

Specific data on acetaminophen prices within the United States and Canada can also be provided.

Middle East and Africa Acetaminophen Price

The report explores the acetaminophen pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on acetaminophen prices for countries can also be provided.

Asia Pacific Acetaminophen Price

The prices of acetaminophen were considerably on the rise in Asian markets, thus prompting the government to place certain measures to regulate the prices to an acceptable level. As medical inflation rates continued to rise by over 10 percentage points, pharmaceutical industries looked for ways to increase prices including basic medicines such as acetaminophen. However, with the interest of making these products affordable for every consumer, the government intervened and put a stop to the rising costs for thirty-three essential medicines, such as acetaminophen. Such intervention led to the linear decrease of the graph of acetaminophen which relates to the fact that the market forces in combination with the governmental legislation play an essential role in providing the people with the essential medications in question while lowering the effects of inflation in case with the healthcare expenditures.

This analysis can be further extended to include detailed acetaminophen prices for a comprehensive list of countries within the region.

Latin America Acetaminophen Price

The analysis of acetaminophen prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of acetaminophen pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting acetaminophen price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the acetaminophen industry.